Literature DB >> 13679388

Immunogenicity of Peptide-25 of Ag85B in Th1 development: role of IFN-gamma.

Ai Kariyone1, Toshiki Tamura, Hideyuki Kano, Yoichiro Iwakura, Kiyoshi Takeda, Shizuo Akira, Kiyoshi Takatsu.   

Abstract

Ag85B (also known as alpha antigen or MPT59) is immunogenic, and induces expansion and differentiation of TCRVbeta11(+)CD4(+) T cells to IFN-gamma-producing cells in C57BL/6 (I-A(b)) mice. We reported that Peptide-25 (amino acids 240-254) of Ag85B is a major T cell epitope, and its amino acid residues at position 244, 247, 249 and 252 are I-A(b) contact residues. Here we examined roles of IFN-gamma in the generation of Peptide-25-reactive CD4(+) TCRVbeta11(+) T cells and the efficacy of mutant peptides of Peptide-25 for T(h)1 development in mice other than C57BL/6 mice. Immunization of C57BL/6 mice with Peptide-25 included in incomplete Freund's adjuvant led to preferential induction of CD4(+) TCRVbeta11(+) IFN-gamma- and tumor necrosis factor-alpha-producing T cells. Compared with other I-A(b)-binding peptides such as Peptide-9 of Ag85B, 50V of pigeon cytochrome c and ovalbumin (OVA)(265-280) peptide, only Peptide-25 was capable of inducing enormous expansion of TCRVbeta11(+) IFN-gamma-producing T cells. Treatment of C57BL/6 mice with anti-Vbeta11 antibody before Peptide-25 immunization reduced the development of CD4(+) IFN-gamma-producing T cells. Furthermore, B10.A(3R) mice, I-A(b)-positive and TCRVbeta11(-) strain, showed remarkably lower response to Peptide-25 immunization than C57BL/6 mice. Peptide-25-primed IFN-gamma(-/-) cells showed significantly decreased expansion of CD4(+) TCRVbeta11(+) T cells as compared with wild-type cells. Interestingly, Peptide-25-primed cells from MyD88-deficient mice responded to Peptide-25 and differentiated into IFN-gamma-producing cells to a similar extent as wild-type mice, indicating Toll-like receptor-independent IFN-gamma production. These results imply that IFN-gamma plays important roles for the generation and expansion of CD4(+) TCRVbeta11(+) T cells in response to Peptide-25. Although Peptide-25 was non-immunogenic in C3H/HeN mice, a substituted mutant of Peptide-25, 244D247V, capable of binding to I-A(k), induced T(h)1 development. These results clearly demonstrate important roles of IFN-gamma in the expansion of CD4(+) TCRVbeta11(+) T cells, and will provide useful information for delineating the regulatory mechanisms of T(h)1-cell development and for analyzing mechanisms on T(h)1-dominant immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679388     DOI: 10.1093/intimm/dxg115

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.

Authors:  Takeshi Kikuchi; Shuichiro Uehara; Haruyuki Ariga; Takeshi Tokunaga; Ai Kariyone; Toshiki Tamura; Kiyoshi Takatsu
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

2.  The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.

Authors:  Claire Swetman Andersen; Jes Dietrich; Else Marie Agger; Nils Y Lycke; Karin Lövgren; Peter Andersen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

3.  Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.

Authors:  Haruyuki Ariga; Yoko Shimohakamada; Makiyo Nakada; Takeshi Tokunaga; Takeshi Kikuchi; Ai Kariyone; Toshiki Tamura; Kiyoshi Takatsu
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

4.  Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses.

Authors:  Aditi Varthaman; Marc Clement; Jamila Khallou-Laschet; Giulia Fornasa; Anh-Thu Gaston; Michael Dussiot; Giuseppina Caligiuri; Harvey Cantor; Srinivas Kaveri; Antonino Nicoletti
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

5.  Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice.

Authors:  Megan A Files; Kubra F Naqvi; Tais B Saito; Tara M Clover; Jai S Rudra; Janice J Endsley
Journal:  NPJ Vaccines       Date:  2022-04-26       Impact factor: 9.399

6.  STAT3 expression by myeloid cells is detrimental for the T- cell-mediated control of infection with Mycobacterium tuberculosis.

Authors:  Yu Gao; Juan Ignacio Basile; Cajsa Classon; Dolores Gavier-Widen; Akihiko Yoshimura; Berit Carow; Martin E Rottenberg
Journal:  PLoS Pathog       Date:  2018-01-16       Impact factor: 6.823

7.  Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice.

Authors:  Takahiro Nagatake; Hidehiko Suzuki; So-Ichiro Hirata; Naomi Matsumoto; Yasuko Wada; Sakiko Morimoto; Ayaka Nasu; Michiko Shimojou; Mitsuo Kawano; Kentaro Ogami; Yusuke Tsujimura; Etsushi Kuroda; Norifumi Iijima; Koji Hosomi; Ken J Ishii; Tetsuya Nosaka; Yasuhiro Yasutomi; Jun Kunisawa
Journal:  Int Immunol       Date:  2018-09-25       Impact factor: 4.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.